ClearPoint Neuro Inc. (CLPT) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ClearPoint Neuro Inc. (CLPT:NASDAQ), powered by AI.

Current Price
$13.44
Sector
Healthcare
What is the ClearPoint Neuro Inc. stock price forecast?

ClearPoint Neuro Inc. is currently trading at $13.44. View real-time AI analysis on Alpha Lenz.

What is ClearPoint Neuro Inc. insider trading activity?

View the latest insider trading data for ClearPoint Neuro Inc. on Alpha Lenz.

What is ClearPoint Neuro Inc.'s P/E ratio?

View ClearPoint Neuro Inc.'s valuation metrics on Alpha Lenz.

ClearPoint Neuro Inc.

NASDAQ · CLPT
$13.44-0.40(-2.89%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about ClearPoint Neuro Inc.'s future dividend policy...
Alpha Chat Insight

ClearPoint Neuro Inc.'s ROE is -95.6%. Explore profitability and growth together.

Ask for details

Company Overview

ClearPoint Neuro Inc. is an innovative medical device company that specializes in the development and commercialization of platform tech aimed at navigating the brain. Primarily, it focuses on providing real-time MRI-guided systems that enhance the precision and safety of interventions in neurological surgeries. These systems are designed to facilitate a range of procedures, including biopsies, tumor resection, and the delivery of therapeutics directly into the brain. By offering products that integrate seamlessly with existing MRI machinery, ClearPoint Neuro Inc. significantly impacts sectors like healthcare and neuroscience, providing vital tools to enhance surgical accuracy and patient outcomes. Positioned at the intersection of technology and medicine, ClearPoint Neuro holds a pivotal role in the marketplace for advanced medical solutions, aiding in the progress of precision medicine and expanding the possibilities for treatments of neurological conditions.

CEOMr. Joseph Michael Burnett
SectorHealthcare
IndustryMedical Devices
Employees115

Company Statistics

FY 2025

Profile

N/AMarket Cap
$36.97MRevenue
0.00Shares Out
115Employees

Margins

61.38%Gross
-56.42%EBITDA
-65.36%Operating
-68.93%Pre-Tax
-69.08%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

21.62%Rev 3Yr
23.58%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-37.30%ROA
-95.64%ROE
-33.73%ROIC

Financial Health

$45.92MCash & Cash Equivalents
$23.80MNet Debt
248.85%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

ClearPoint Neuro Inc. (ticker: CLPT) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 115 employees.

The current price is $13.44 with a P/E ratio of -x and P/B of -x.

ROE is -95.64% and operating margin is -65.36%. Annual revenue is $37M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
ClearPoint Neuro Inc. (CLPT) Stock Forecast 2026 $13.44 — Price, Financials & Analyst Targets | Alpha Lenz